News and Press Releases
Press releases
Theralase Provides Corporate Update
Press ReleaseToronto, Ontario – August 17, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and d...
Theralase Achieves 98% Destruction of Bladder Cancer
Press ReleaseToronto, Ontario – July 22, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and des...
Theralase Appoints Experienced Sales and Marketing Team to Launch Next Generation Therapeutic Laser
Press ReleaseToronto, Ontario – July 17, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and des...
Theralase Appoints Director of Investor Relations
Press ReleaseToronto, Ontario – July 16, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and des...
Theralase to Present at BIO Conference
Press ReleaseToronto, Ontario – June 18, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC Pink®), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain ...
Theralase Releases Next Generation Therapeutic Laser to Select Healthcare Practitioners and Sales Team
Press ReleaseToronto, Ontario – June 11, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC Pink®), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain ...
Next Generation Therapeutic Laser Receives Safety Approval
Press ReleaseToronto, Ontario – June 10, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC Pink®), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain ...
Theralase Increases Revenue 2% in Q1 2015 Financials
Press ReleaseToronto, Ontario – May 29, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT: TSXV) (TLTFF: OTC Pink®), a medical laser company dedicated to commercializing technology to heal pain and destroy cancer, relea...
Theralase Grants Stock Options
Press ReleaseToronto, Ontario – May 28, 2015 Theralase Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (TLTFF: OTC Pink®), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain ...
Theralase Presents Latest Scientific Research at 15th International Photodynamic Association World Congress
Press ReleaseToronto, Ontario – May 27, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF: OTC Pink®), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain ...
in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
